Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes

NCT06403761 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Semaglutide
DRUG: Cagrilintide
DRUG: Placebo semaglutide
DRUG: Placebo cagrilintide

Sponsor

Novo Nordisk A/S